title: L41. Perspectives on the treatment of giant cell arteritis.
authors.affiliation: Center for Vasculitis Care and Research, Cleveland Clinic, Department of Rheumatic and Immunologic Diseases, Cleveland, OH 44195, United States. langfoc@ccf.org
authors.forename: Carol A
authors.initials: CA
authors.lastname: Langford
mesh_terms: D000209:Acute-Phase Proteins / Q000032:analysis; D000368:Aged; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001799:Blood Sedimentation; D002545:Brain Ischemia / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy; D003952:Diagnostic Imaging; D004359:Drug Therapy, Combination; D013700:Giant Cell Arteritis / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D005938:Glucocorticoids / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D008875:Middle Aged; D009901:Optic Nerve Diseases / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D000209:Acute-Phase Proteins; D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D007166:Immunosuppressive Agents